Survival of red blood cells after transfusion: processes and consequences by Bosman, G.J.C.G.M.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/140543
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
REVIEW ARTICLE
published: 18 December 2013
doi: 10.3389/fphys.2013.00376
Survival of red blood cells after transfusion: processes and
consequences
Giel J. C. G. M. Bosman*
Department of Biochemistry, Radboud University Medical Centre, Nijmegen, Netherlands
Edited by:
Anna Bogdanova, University of
Zurich, Switzerland
Reviewed by:
Enrique Hernandez-Lemus, National
Institute of Genomic Medicine,
Mexico
Giampaolo Minetti, University of
Pavia, Italy
*Correspondence:
Giel J. C. G. M. Bosman,
Department of Biochemistry (286),
Nijmegen Centre of Molecular Life
Sciences and Radboud University
Medical Centre, PO Box 9101,
NL-6500 HB Nijmegen, Netherlands
e-mail: g.bosman@ncmls.ru.nl
The currently available data suggest that efforts toward improving the quality of red
blood cell (RBC) blood bank products should concentrate on: (1) preventing the removal
of a considerable fraction of the transfused RBCs that takes place within the first
hours after transfusion; (2) minimizing the interaction of the transfused RBCs with the
patient’s immune system. These issues are important in reducing the number and
extent of the damaging side effects of transfusions, such as generation of alloantibodies
and autoantibodies and iron accumulation, especially in transfusion-dependent patients.
Thus, it becomes important for blood bank research not only to assess the classical
RBC parameters for quality control during storage, but even more so to identify the
parameters that predict RBC survival, function and behavior in the patient after transfusion.
These parameters are likely to result from elucidation of the mechanisms that underly
physiological RBC aging in vivo, and that lead to the generation of senescent cell
antigens and the accumulation of damaged molecules in vesicles. Also, study of RBC
pathology-related mechanisms, such as encountered in various hemoglobinopathies and
membranopathies, may help to elucidate the mechanisms underlying a storage-associated
increase in susceptibility to physiological stress conditions. Recent data indicate that a
combination of new approaches in vitro to mimick RBC behavior in vivo, the growing
knowledge of the signaling networks that regulate RBC structure and function, and the
rapidly expanding set of proteomic and metabolomic data, will be instrumental to identify
the storage-associated processes that control RBC survival after transfusion.
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INTRODUCTION
The final days of the erythrocyte’s life are characterized by
the appearance of an aging-specific removal signal. The sig-
nal is a neoantigen that is derived from the integral membrane
protein band 3, and the removal is phagocytosis that is ini-
tiated by binding of autologous IgG and subsequent recogni-
tion by macrophages in the liver and possibly in the spleen
(Kay, 1975; Safeukui et al., 2012). Since the seminal papers
of Kay and coworkers (Kay, 1975, 1978, 1981, 1984; Kay and
Bennett, 1982; Kay et al., 1983, 1988a; Safeukui et al., 2012) with
the observations and experiments supporting and/or based on
this concept, recognition of old erythrocytes by a physiological
autoimmune reaction has been generally accepted as responsi-
ble for the physiological disappearance of erythrocytes after 120
days in the circulation (Clark, 1988). However, little progress
has been made with respect to the identity of the molecular
mechanism(s) leading to the formation of the aging or senes-
cent cell-specific antigen. This is the more frustrating, since the
erythrocyte has the potential of becoming a model for cellular
aging, as it once was for membrane structure. Also, the exper-
imental and conceptual framework that has arisen around this
concept, has the potential of becoming instrumental in the gen-
eration of biomarkers of various diseases, and in the expansion
of our knowledge of the regulation of cell morphology and
metabolism.
The aging framework is commonly—and often implicitly—
used to interpret the molecular events occurring during erythro-
cyte storage in blood bank conditions (Bosman et al., 2008a,
2010a). The link between aging in vivo and aging in vitro is
extended by the study of hereditary anemias caused by increased
erythrocyte removal. The resulting triangle has been given at least
one extra dimension by recent data indicating that, at the cur-
rent scientific and technical level, the truly relevant blood bank
conditions are not those that determine erythrocyte survival in
the blood bank, but those that affect function and survival after
transfusion (Bosman et al., 2011). Yet another, new dimension is
formed by the status of the erythrocyte-receiving patient, e.g., the
activity of the immune system and/or the spleen, as an effector
of the survival of the transfused erythrocytes (Gould et al., 2007;
Dinkla et al., 2012a,b).
The present review starts with a summary of the currently
available knowledge of the molecular structure, function and
metabolism of the aging erythrocyte in the healthy individual.
This summary is the starting point for a review of the data
obtained in vitro and from patients with hereditary erythrocyte
pathologies, based on the view that this may help to deduce the
most likely molecular mechanism(s) leading to the aged phe-
notype. The resulting synthesis constitutes the framework for a
discussion of the storage lesions, focussing on their impact on the
survival of erythrocytes after transfusion.
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CHARACTERISTICS OF ERYTHROCYTE AGING in vivo
An overview on the available data, strictly limited to those
obtained by analysis of erythrocyte aging in vivo in healthy people,
shows the following:
LIFESPAN
The maximal lifespan of erythrocytes is 120 days, with a rather
small variation of approximately 10 percent. This variation may
be due to variations in methodology, such as the analysis of
appearance and disappearance of metabolic labels from the cir-
culation, and of the disappearance of erythrocytes labeled with
various markers after autologous transfusion, or after transfusion
of erythrocytes with differences in minor blood groups (Werre
et al., 2004; Bosman et al., 2012a). Alternatively, the variability in
maximal lifespan may also be due to inter-individual variations
in erythrocyte homeostasis, as has become apparent especially in
recent blood bank donor research (Wenk et al., 2011; Dinkla et al.,
2013). The relatively small variation in lifespan observed in all
studies, however, suggests a gradual, multi-stepmechanism rather
than a random, disastrous insult, as well as a very efficient removal
process.
VOLUME AND DENSITY
With increasing time in the circulation, erythrocytes become
smaller and more dense. A detailed analysis of these changes
shows that, with age, erythrocytes loose 30% of their volume and
15–20% of their hemoglobin, whereas the hemoglobin concen-
tration increases by 14%. This implies that, with age, erythrocytes
lose proportionally more water than hemoglobin. Because the
decrease in volume is larger than the decrease in surface area,
the surface to volume ratio increases. This theoretically posi-
tive effect on deformability is abolished by the increase in the
hemoglobin concentration, and probably by a decrease in the
membrane elasticity (Bosch et al., 1994). Using the percent-
age of glycated hemoglobin, HbA1c, as a marker of cell age in
combination with cohort labeling, survival studies and hemocy-
tometry, Werre and coworkers (Van der Vegt et al., 1985; Bosch
et al., 1992, 1994) established that age-related purification of
cell fractions on the basis of density alone has inherent restric-
tions. A similar conclusion can be drawn using another cell age
marker, the 4.1a:4.1b ratio, which increases as the result of non-
enzymatic deamidation (Mueller et al., 1987; Lutz et al., 1992;
Ciana et al., 2004). The lighter fractions are strongly enriched
for reticulocytes and young erythrocytes, but the dense frac-
tions are much more heterogeneous with respect to cell volume
and cell age. When counterflow centrifugation is followed by
density centrifugation, the mean corpuscular volume decreases
from 101 fl in the fraction containing the lightest and largest
erythrocytes to 72 fl in the fraction with the most dense and
smallest cells (Bosch et al., 1992). Combining the two separa-
tion techniques results in a considerable reduction in the cell
volume-based distribution curves, an almost complete absence
of overlap in the erythrocytograms of the lighter-larger and the
denser-smaller fractions, and the largest difference in the percent-
age HbA1c between these fractions (Bosch et al., 1992). Thus, a
combination of separation techniques based on volume and den-
sity yields erythrocyte fractions with a greater difference in mean
cell age than does separation on the basis of density or volume
alone.
VESICULATION
Based on observations in splenectomized individuals and on the
analysis of subcellular blood fractions, it has been postulated
that, under normal conditions, vesiculation is responsible for the
aging-associated loss of hemoglobin. The striking resemblance
between the hemoglobin composition of blood-borne vesicles
and that of old erythrocytes, supports the conclusion that there
is a continuous loss of hemoglobin in vesicles, which acceler-
ates during the second half of the erythrocyte lifespan (Willekens
et al., 2003). In the oldest erythrocytes of asplenic individu-
als, the decrease in hemoglobin is absent, concomitant with an
increase in the absolute amounts of glycated and otherwise mod-
ified hemoglobin species (Willekens et al., 2003). Together with
the previous observations that erythrocytes of patients without
a functional spleen have an increased number of hemoglobin-
containing vacuoles (Reinhart and Chien, 1988), and that there
is a positive relation between the vacuole-containing erythrocytes
and the percentage HbA1c (De Haan et al., 1988), these data sug-
gest that hemoglobin-containing vesicles within old erythrocytes
are removed from the erythrocytes in the spleen. However, it is
not likely that vesiculation and vesicle removal occur only in the
spleen. A rough calculation based on the vesicle concentrations
measured in the blood (Willekens et al., 2008), combined with
the kinetics of vesicle disappearance as measured in a rat model
(Willekens et al., 2005), indicates that erythrocyte-derived vesi-
cles are phagocytized almost directly after they are generated, even
before they can reach the venous circulation. Immunological, bio-
chemical and proteomic analysis of the vesicles generated in vivo
suggests that their origin and removal are intimately interwoven
with the erythrocyte aging process, and especially with break-
down of band 3 (Willekens et al., 2008; Bosman et al., 2008a,
2012b). The increase in erythrocyte-derived vesicles described
in various pathological conditions, most of which are directly
related to erythrocyte-specific abnormalities in hemoglobin or
membrane proteins, suggests a disturbed aging process in these
diseases (Kozuma et al., 2011; Mahfoudhi et al., 2012). However,
it has become clear that vesicles may be generated by various
mechanisms, emphasizing the need for extensive analysis of these
vesicles and comparison with those generated in healthy individ-
uals (Willekens et al., 2005, 2008; Bosman et al., 2010a, 2012b;
Kozuma et al., 2011; Xiong et al., 2011; Mahfoudhi et al., 2012;
Nantokomol et al., 2012).
REMOVAL SIGNALS
Alterations in band 3, as indicated by the presence of breakdown
products and/or band 3-containing high-molecular-weight com-
plexes, constitute themost consistent finding in themembranes of
old erythrocytes (Kay, 2005; Pantaleo et al., 2008; Willekens et al.,
2008; Bosman et al., 2010a,b). Together with the specificity of the
senescent cell-specific IgG, this implies a band 3-derived antigen
as the main factor responsible for the removal of old erythro-
cytes from the circulation. There is no convincing evidence for the
involvement of phosphatidylserine (PS) in physiological removal
of healthy, aged erythrocytes (Willekens et al., 2008; Franco et al.,
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2013). Recently, however, data have been presented indicating the
involvement of the “self” antigen CD47 in phagocytosis of old
erythrocytes (Burger et al., 2012). The observations that vesicles
are enriched in IgG and band 3 breakdown products, and that
most of them expose PS at their surface, have led to the theory
that vesiculation serves to dispose damaged membrane patches
(Willekens et al., 2008; Tissot et al., 2010). This mechanism would
postpone the elimination of functional erythrocytes, and the fast
removal of vesicles may prevent uncontrolled coagulation and
inflammation (Xiong et al., 2011; Mahfoudhi et al., 2012). The
current state of knowledge as described here is schematically
depicted in Figure 1.
MECHANISMS OF ERYTHROCYTE AGING in vivo
So far, the data of the last decade have mostly confirmed and
extended, but not deepened the picture sketched in the preceding
paragraphs (Kay, 2005; Pantaleo et al., 2008; Franco et al., 2013).
Incorporation of the vesicle characteristics into the aging process
supports the putative early involvement of hemoglobin, and the
central role of band 3 in the aging process (Salzer et al., 2008;
Willekens et al., 2008; Tissot et al., 2010; Bosman et al., 2012b).
The cytoplasmic domain of band 3 is a central mediator of the
concentration of ATP, 2,3-DPG, NADH and NADPH (Messana
et al., 1996; Chu et al., 2008; Rogers et al., 2009; Dzik, 2011).
Thereby, aging-associated changes in band 3 connect changes
in cell morphology and volume, deformability, and interaction
between cytoskeleton and lipid bilayer with changes in the activity
of the glycolytic and the pentose phosphate pathways, and pos-
sibly ion transport and release of ATP and NO as well. Binding
of oxidatively modified hemoglobin, the so-called hemichromes,
to the cytoplasmic domain of band 3 is likely to alter its con-
formation, and may thereby induce aggregation and/or increase
its susceptibility to proteases. An aging-related increase in oxida-
tion of membrane lipids and proteins may catalyze this process.
Indeed, recent proteomic data show an aging-associated mem-
brane recruitment of chaperone proteins, indicating denatura-
tion and exposure of hitherto hidden protein domains (Bosman
et al., 2012b). Also, metabolomic and biochemical data suggest
a decrease in anti-oxidation defense, together with a decrease
of glycolytic activity in erythrocytes aged in vivo (Bosman and
Kay, 1988; Ghashghaeinia et al., 2012; D’Alessandro et al., 2013a).
Alterations in the cytoplasmic domain of band 3 also affect bind-
ing of ankyrin, and loss of anchorage at this junction of the
spectrin cytoskeleton to the lipid bilayer is the most likely cause of
the formation of vesicles observed in vivo, and explains much of
their protein composition (Sens and Gov, 2007; Gov et al., 2009).
Erythrocyte aging in humans can be studied experimentally only
in vitro, and physiological erythrocyte removal in mice is likely to
differ too much from that in humans to expect that mouse studies
will lead to new, relevant developments in this area (Khandelwal
and Saxena, 2008). Therefore, support for the mechanisms
that have been deduced from theory-driven or inventory-based
comparisons of erythrocytes of various ages, has been sought
in various erythrocyte-centered diseases. Detailed analysis of
hemoglobinopathies, such as sickle cell disease and hemoglobin
Köln, supports the relationship between hemoglobin deposition
at themembrane, immunoglobulin binding, and also vesiculation
(Kay et al., 1988b; Westerman et al., 2008). Immunoblot analy-
sis of HbS-containing erythrocytes show sickling-associated and
aged cell-like band 3 patterns (Bosman, 2004).
Altered vesiculation may underly the aberrant erythrocyte
morphology caused by genetic abnormalities in band 3, ankyrin
or spectrin leading to elliptocytosis. The role of the spleen in
vesiculation is confirmed by the beneficial effect of splenectomy
in these patients (An and Mohandas, 2008). It is noteworthy
that the elliptocytosis-associated mutations are all located in the
membrane domain of band 3, illustrating the complexity of the
processes involved. This is supported by the observation that
FIGURE 1 | The life and death of the erythrocyte. The numbers refer to the putative steps in the generation and recognition of removal signals.
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band 3 mutations may also be associated with ovalocytosis or
with stomatocytosis (Delaunay, 2007). Since the main trigger
for erythrocyte loss in G6PD-deficient erythrocytes is oxidative
stress (Beutler, 2008), erythrocytes of affected individuals have
been used to investigate the role of oxidation in aging-associated
changes in band 3. The results support a connection between
hemoglobin denaturation, vesicle formation, oxidation and phos-
phorylation of band 3 (Minetti et al., 1996; Pantaleo et al., 2011).
The latter is in line with the recent awareness of the activity
in the erythrocyte of multiple signaling pathways that regulate
the interaction of membrane proteins with eachother and with
cytosolic proteins. Especially research of the mechanisms that
regulate recruitment and activity of kinases and phosphatases is
likely to reveal more insight into the processes underlying main-
tenance and loss of erythrocyte morphology and metabolism in
health, disease and aging.
Over the years, data from comparing young with old, and con-
trol with pathological erythrocytes, have provided the tools not
only to investigate erythrocyte aging in disease, but also to test
theories on aging mechanisms in vitro (Bosman and Kay, 1988).
The latter has led to two main conclusions: 1, investigation of any
aging-associated susceptibility to physiological stress-mimicking
conditions may reveal the most relevant lesions at the molecular
level, and themechanisms leading to these lesions (Ghashghaeinia
et al., 2012); 2, the experimental treatment that results in the
highest degree of similarity in morphological, structural, and
functional changes to those observed during aging in vivo, is stor-
age in blood bank conditions (Bosman and Kay, 1988). Oxidation
in vitro or reduced protection against oxidative damage in vitro
and in vivo are second best (Bosman and Kay, 1988; Kay et al.,
1988a; Burger et al., 2013).
BLOOD BANK STORAGE, AGING, AND REMOVAL AFTER
TRANSFUSION
There are many excellent articles and reviews on what happens
with the erythrocyte during its sojourn in the blood bank (Hess,
2012). Here we summarize and discuss these events in relation
to the aging process in vivo, and to their possible effect on their
survival after transfusion.
LIFESPAN
Erythrocyte survival and lifespan measurements obtained with
transfused erythrocytes are in good accordance with those
obtained using metabolic labeling studies, indicating an over-
all good survival with a maximum of 135 days after transfusion
(Mollison et al., 1987; Luten et al., 2004). However, almost
all studies show the disappearance of 5–10% within the first
24 h after transfusion, which is followed by a linear disappear-
ance curve. This percentage of rapidly disappearing erythrocytes
increases with storage time to 25% or more (Luten et al., 2008a).
These data suggest that, during their stay in the blood bank,
erythrocytes become increasingly vulnerable to as yet unknown
stressful conditions they encounter after transfusion. We have
postulated that the fraction of quickly disappearing erythrocytes
is the main cause of the adverse events of transfusions, especially
in transfusion-dependent patients. An overload of the reticulo-
endothelial system could lead to hemolysis and the accumulation
of neoantigens, triggering iron acccumulation, inflammation and
the formation of alloantibodies.
VOLUME AND DENSITY
Blood bank storage affects volume regulation as indicated, among
other things, by the increase in erythrocyte volume already in
the first week of storage (Luten et al., 2008b). This is most likely
due to the far from physiological composition of most storage
solutions, and seems to be readily reversible upon incubation
in buffers with a pH and ion concentrations similar to those of
the blood. As a complicating factor, storage may affect cation
transport and volume regulation differently in young and old
erythrocytes (Minetti et al., 2001). There is a striking change
in erythrocyte shape with storage, apparently progressing from
echinocytes and stomatocytes to an irreversible spherocyte mor-
phology (Blasi et al., 2012). Density separation results in cell
fractions in which the increase in density is accompanied by an
increase in HbA1c, suggesting that this method is, in principle,
also suitable for the study of aging in vitro (D’Alessandro et al.,
2013b). It is tempting to speculate that the more severely and
apparently irreversibly deformed erythrocytes comprise at least
a fraction of the removal-prone erythrocytes. Cell volume and
density are important factors in deformability. Most data indi-
cate that deformability may decrease with storage time, but to
an extent that depends heavily on the methods to measure this
parameter. The outcomes of most ektacytometry measurements,
for example, are likely to be determined by a decrease in the
surface/volume ratio, resulting from vesiculation, and a possibly
compensatory decrease in the cellular hemoglobin concentration
(Cluitmans et al., 2012).
VESICULATION
The availability of an easily accessible source of relatively pure
preparations in the form of erythrocyte concentrates in the blood
bank has enabled the generation of many data on storage vesicles
(Greenwalt, 2006). However, there is no comprehensive theory
on the mechanism of their generation, or on their putative con-
tribution to the adverse side effects of transfusion. Blood bank
vesicles are enriched in modified hemoglobin species, as are the
erythrocyte-derived vesicles in the plasma (Willekens et al., 2003;
Bosman et al., 2008a). Their membrane protein composition,
on the other hand, is different from that of erythrocyte-derived
vesicles from the plasma, suggesting different vesiculation mech-
anisms in vitro and in vivo (Greenwalt, 2006; Bosman et al.,
2008b; Kriebardis et al., 2008; Salzer et al., 2008). Also, blood
bank vesicles containmore and different plasma-derived proteins,
especially immunoglobulins and complement proteins (Bosman
et al., 2008b; Kriebardis et al., 2008). The comparison of blood
bank vesicles with plasma vesicles is complicated by their accumu-
lation over time in the blood bag, as this results in a heterogeneity
in vesicle age that is likely to be much higher than those of
freshly isolated vesicles. Also, there is a distinct possibility that the
mechanism of vesiculation changes with storage time and stor-
age medium (Greenwalt and Dumaswala, 1988; Bosman et al.,
2010a; Sparrow et al., 2013). A more extensive study especially
of the biological activity of blood bank vesicles is warranted by
their biological activity, and likely effect on the circulation and
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immune system of the patient (Gould et al., 2007; Donadee et al.,
2011; Kozuma et al., 2011; Xiong et al., 2011).
REMOVAL SIGNALS AND MECHANISMS
Band 3 is very sensitive to proteolytic breakdown, as becomes
apparent not only upon immunoblot analysis of purified ery-
throcytes kept in physiological buffer solutions, but also when
stored as whole blood or during storage in blood bank condi-
tions. This sensitivity is most apparent using antibodies against
parts of the cytoplasmic domain, suggesting that this domain is
especially vulnerable (Bosman et al., 2008a). The changes in this
domain are likely to affect the connection between lipid bilayer
and the cytoskeleton, and the binding of key enzymes of the
glycolysis. Thus, early changes in the cytoplasmic domain may
very well be responsible for the storage-associated changes in
erythrocyte morphology and metabolism. On the other hand,
new metabolomic data support the hypothesis that storage exac-
erbates the effect of naturally occurring oxidative stress by dis-
turbing the physiological balance between glycolysis, pentose
phosphate pathway, and glutathione homeostasis (Gevi et al.,
2012; Rinalducci et al., 2012). The apparent reversibility of these
changes, especially within the first weeks of storage, may be
explained by the redundancy of available binding sites. There are
much more band 3 than ankyrin molecules, and the dynamic
equilibrium between band 3 monomers, dimers and tetramers
may compensate for a small decrease in ankyrin-binding (or
enzyme-binding) sites.
The number of IgG molecules that is bound per erythrocyte
only slightly increases with storage time. Even after the maximal
storage period, the percentage of erythrocytes with an amount
of IgG that is sufficient for recognition by macrophages is still
very small (Kay, 2005). It is noteworthy that the binding of IgG
increases within the first weeks of storage, and then decreases
again (Luten et al., 2004; Dinkla et al., 2012a). We speculate
that this may be caused by the lysis of the very old erythro-
cytes early in the storage period, leading to association of spectrin
or actin to other, intact cells. This could trigger the binding of
low-affinity antibodies, that are normally present in the blood
(Garratty, 2005). The number of IgG-containing erythrocytes at
the end of the maximal storage time, even after incubation with
autologous plasma, is much lower than predicted if the aging pro-
cess in vitro would proceed in an identical manner and with the
same speed as it does in vivo. If the latter scenario, the percent-
age of senescent cell antigen-exposing (and thus IgG-containing)
erythrocytes would be much higher than observed, even when
corrected for the difference in temperature. Therefore, we must
conclude that storage in blood bank conditions may have some
molecular features of aging in vivo (see also Figure 1), but that
the processes underlying the fast removal of up to 30 percent of
the erythrocytes after transfusion cannot be ascribed to a physi-
ological aging process. The recently described, storage-associated
increase in the binding of IgG from patients with autoimmune
hemolytic anemia to blood bank erythrocytes, shows that aging
in vitro may, in certain conditions, assume a pathological form
(Dinkla et al., 2012a).
Similarly, the very small increase in the number of PS-exposing
erythrocytes during storage is far from sufficient to explain the
fast removal of up to 30 percent of the stored erythrocytes
after transfusion (Verhoeven et al., 2006; Bosman et al., 2011).
However, with storage the erythrocytes become very sensitive to
stress-induced PS exposure, especially to the near-physiological
stress consisting of incubation in a hyperosmotic buffer (Bosman
et al., 2011). Together with a concomitant storage-associated
increase in susceptibility to generate vesicles (Burger et al., 2013),
this observation emphasizes the predisposing, “sublethal” nature
of the events that occur in the blood bank.
In a probably analogous manner, there is a detectable change
in CD47 conformation during storage only after transfusion
in vitro, i.e., after incubation of the stored erythrocytes with whole
blood (Burger et al., 2012). Also, storage is associated with an
increased sensitivity to a band 3 ligand-induced binding of autol-
ogous IgG (Bosman et al., 2010b). The storage-associated increase
in sensitivity to lipase-induced morphological and biochemical
alterations points toward a hitherto little-studied involvement of
lipids and lipid organization in erythrocyte vesicle formation and
antigen presentation (Salzer et al., 2008; Dinkla et al., 2012b).
In general, parameters for a “sublethal injury” such as these are
likely to carry more physiologically and clinically relevant weight
than osmotic or mechanical fragility (Raval et al., 2010, 2013;
Cluitmans et al., 2012).
CONCLUSIONS
The presently available data show that neither our knowledge of
the identity of themolecules that signal removal of physiologically
aged erythrocytes, nor of the identity of the mechanisms by which
they are generated, has progressed much in the last two decennia.
One notable exception is the incorporation of vesicle formation in
the aging process in vivo (Willekens et al., 2008). This is in spite
of the strong increase in the number of the phenomena described
to accompany especially erythrocyte aging in vitro. The recent
increase in the number of data on the presence and activity of
signaling pathways regulating erythrocyte function, morphology
and metabolism, mostly resulting from disease-centered research,
opens new possibilities to unravel the mechanisms involved in
erythrocyte aging in vivo as well as in vitro. Regarding the lat-
ter, all present data show that storage may be the best available
model for studying erythrocyte aging, but do not support the
theory that storage in the blood bank is an accelerated form of
physiological aging or of a pathological form of aging in vivo. This
supports the statement that there is still a poor understanding of
the storage lesion and its effect on erythrocyte performance. In
the view presented here, the most recent data indicate that the
processes that occur during storage render the erythrocytes espe-
cially vulnerable to the aging phenotype-inducing conditions they
encounter after transfusion in the circulation. The increase in sus-
ceptibility to stress-induced PS exposure and shrinkage that also
occurs during aging in vivo (Ghashghaeinia et al., 2012), provides
a functional connection between aging in vitro and aging in vivo.
In this context, a recent definition of aging as a “de-tuning of
adaptation with increasing age” seems to be directly applicable
at the cellular level (Raval et al., 2013).
This leads to the practical conclusion that future research on
improving erythrocyte survival after transfusion should concen-
trate on relating the changes, observed in erythrocytes during
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storage, to their resistance to physiological stress that induces
the appearance of removal signals after transfusion. This stress
could be mechanical, e.g., as experienced during passage through
the microcapillaries and the spleen, but also biochemical, e.g., as
occurring during the gradual exhaustion of the defense against
oxidation and oxidation-induced protein denaturation. Together
with the available knowledge on the identity of removal sig-
nals, and the identification of the relevant signaling pathways
that is likely to happen in the near future, this approach pro-
vides a sorely needed, experimental platform to investigate the
mechanisms responsible for the dangerous, fast removal of a
considerable fraction of the blood bank erythrocytes early after
transfusion.
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